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Abstract
Background: This article describes the development and psychometric evaluation of an interview
instrument to assess provider-reported quality of general practice care for patients with diabetes,
cardiovascular disease and asthma – the Australian General Practice Clinical Care Interview
(GPCCI).
Methods: We administered the GPCCI to 28 general practitioners (family physicians) in 10
general practices. We conducted an item analysis and assessed the internal consistency of the
instrument. We next assessed the quality of care recorded in the medical records of 462 of the
general practitioners' patients with Type 2 diabetes, ischaemic heart disease/hypertension and/or
moderate to severe asthma. This was then compared with results of the GPCCI for each general
practice.
Results: Good internal consistency was found for the overall GPCCI (Cronbach's alpha = 0.75).
As far as the separate sub-scales were concerned, diabetes had good internal consistency (0.76)
but the internal consistency of the heart disease and asthma subscales was not strong (0.49 and
0.16 respectively). There was high inter-rater reliability of the adjusted scores of data extracted
from patients' medical notes for each of the three conditions. Correlations of the overall GPCCI
and patients' medical notes audit, combined across the three conditions and aggregated to practice
level, showed that a strong relationship (r = 0.84, p = 0.003) existed between the two indices of
clinical care.
Conclusion: This study suggests that the GPCCI has good internal consistency and concurrent
validity with patients' medical records in Australian general practice and warrants further evaluation
of its properties, validity and utility.
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Chronic conditions such as diabetes, cardiovascular dis-
ease, asthma and depression impose a significant chal-
lenge to health systems throughout the world
contributing 47% to the global burden of disease[1]. In
Australia, such conditions account for 70% of the total
burden of disease[2]. The majority of chronic disease care
takes place within general practice and one in four general
practice consultations are for problems associated with
such illnesses[3]. However, in Australia [4-6] and in other
countries [7-9], the care provided in this setting is often
sub-optimal. Several factors contribute. The historical
focus on organisational systems to facilitate acute care in
general practice, which, with its predominant episodic
nature, short consultations and little emphasis on the
patient's role as partner in the care process, hampers the
capacity of general practitioners to undertake high quality,
sustainable chronic disease care[10]. Many chronically ill
patients have multiple conditions as well as complex per-
sonal and social circumstances, yet clinical and social
information is often poorly recorded, even when general
practitioners have a special interest in the management of
a specific chronic illness[11]. In particular, items are often
missing, and frequently it is not known whether the
absence of details about an activity, such as an examina-
tion or a test, is because it has not been performed, or, on
the other hand, it has been performed but not recorded.
Further, information about care relating to the subjective
aspects of a patient's condition, those aspects which con-
stitute the patient's experience of their 'chronic ill-
ness'[12] is often poorly captured.
There is an urgent need for systems within general prac-
tices to deliver information about the care of patients with
multiple conditions in a more comprehensive, systematic
and efficient way, in order to facilitate quality assessment
and, ultimately, quality improvement. However, attempts
to date to conduct simultaneous quality assessment across
multiple conditions have been shown to be problem-
atic[13]. In addition to the poor quality of data recorded,
low prevalence of some items of care and unreliable data
extraction processes are common and they prevent relia-
ble assessment. The solution, according to some profes-
sionals, is to develop more efficient and reliable data
extraction methods[14]. However, such an approach does
not address the variable quality of data in patients' medi-
cal notes and the large investment of resources needed to
extract those data reliably. Nor does it capture the subjec-
tive aspects of quality of care, where the general practi-
tioner knows the patient's personal circumstances and
adjusts care accordingly.
In this paper, we report on a new instrument, a structured
interview schedule that provides simultaneous assessment
of provider-reported quality across three chronic condi-
tions within a general practice setting. The main objectives
of the paper are twofold: (a) to describe the development
and characteristics of the Australian General Practice Clin-
ical Care Interview; and (b) to establish the properties of
the instrument, including its reliability and validity.
Methods
Development and description of the General Practice 
Clinical Care Interview
Using Australian published evidence-based clinical guide-
lines containing quality indicators for Type II diabetes,
asthma and ischaemic heart disease/hypertension [15-
18], we developed the Australian General Practice Clinical
Care Interview (GPCCI), a structured interview instru-
ment to assess the provider-reported care delivered by
general practitioners to patients with Type II diabetes,
moderate to severe asthma and/or ischaemic heart dis-
ease/hypertension. A detailed mapping of the guidelines
against the GPCCI is in Appendix I [see Additional file 1].
Experts who were involved in drafting or reviewing the
guidelines reviewed and commented on the GPCCI items.
The GPCCI was then piloted with 5 general practitioners
who were asked to comment on the clarity and compre-
hension of items.
To minimise the opportunity for general practitioners to
answer hypothetically (that is, based on their knowledge
of what constitutes best practice) and to capture instead
what they actually do on a day-to-day basis, we anchored
some of our questions to the general practitioners' specific
patients (e.g. 3 newly diagnosed patients with hyperten-
sion, 3 patients with Type II diabetes who recently had
their HbA1C outside the target range of 7%) and we fol-
lowed up with questions about whether this care was rep-
resentative of the care they usually provided to such
patients, and if not, how it differed. It also enabled us to
capture some of the subjective aspects of quality of care,
where the general practitioner knows the patient's per-
sonal circumstances and adjusts care accordingly. Other
questions asked general practitioners to indicate whether
they had performed certain quality functions and to esti-
mate the proportion of their patients who had received
different aspects of care.
Four key components of care were assessed for each of the
three conditions, as defined by the clinical guidelines:
• case finding, which includes the identification of
patients at risk of the condition and methods of screening
and diagnosis. Item example: How do you identify patients
for assessment of cardiovascular risk factors?
• assessment of the key behavioural and physiological var-
iables and the early detection of complications of the con-
dition. Item example: What proportion of your adult patientsPage 2 of 7
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smoking status in the last 6 months?
• patient education for self management. Item example:
Thinking of your newly diagnosed patients with Type 2 diabe-
tes, please jot down the initials or a description of 3 of them.
Was self-management education provided to these patients? If
yes, who provided it and what did it entail? Was the education
provided to these 3 patients typical of what you normally do
with newly diagnosed diabetes patients? If not, why not and
what is typical?
• ongoing care, which includes how patients who are
poorly controlled are managed (including further assess-
ment, changes to treatment and referral), the use of evi-
denced based guidelines, support for self management,
patient-held records, care planning, follow up and moni-
toring. Item example: How do you follow up people with
asthma who do not attend their appointments?
These four components represent key clinical activities of
general practice in caring for patients with chronic disease
in the Australian health system[19]. The interview sched-
ule consists of 56 questions. Higher clinical scores (max =
78) reflect better clinical care.
Evaluation of the General Practice Clinical Care Interview
We evaluated the psychometric properties of the GPCCI in
two ways. First, we conducted an item analysis and tested
the internal consistency of the overall scale using Cron-
bach's alpha[20]. Then we validated our GPCCI against
the care recorded in the medical records of the general
practitioners' patients with Type 2 diabetes, ischaemic
heart disease/hypertension and moderate to severe
asthma.
Sample
The study was conducted within five Divisions of General
Practice in two Australian states, New South Wales and
South Australia. The Divisions of General Practice issued
invitations to participate in the study to their constituent
general practices. Ten general practices agreed to take part,
representing a mix of practice types, including solo practi-
tioner (3), group (6) and corporate (1). Six of the practices
were in New South Wales, the remaining four were in
South Australia.
General practitioners (family physicians) within each of
the practices were invited to be interviewed. A minimum
sample of 50% of the general practitioners per practice
was set in order to ensure representativeness of the data.
Eligible patients at the same general practices were invited
to participate in the study. Patients were eligible if they
had one or more of the target conditions (Type 2 diabetes,
moderate to severe asthma and ischaemic heart disease/
hypertension, as diagnosed by their general practitioner),
aged 18–85 years old, able to read English sufficiently to
understand the information and consent forms. Patients
were recruited in strict chronological order as they pre-
sented at the participating practices for a consultation. The
number of patients with each condition reviewed within
each practice is in Appendix II [see Additional file 2]. This
shows that there was some variability between practices in
the number of patients with each condition recruited,
however these differences were not statistically significant.
Ethics
The study was approved by the Human Research Ethics
Committees of the University of New South Wales and the
University of Adelaide. Participating general practitioners
and patients received information on the study and com-
pleted a written consent form prior to participation. Prac-
tices were compensated for the time of staff participating
in the study and patients were entered in a draw for three
prizes.
Data collection and analysis
General Practice Clinical Care Interview
The GPCCIs were conducted in the offices of the twenty-
eight participating general practitioners. Due to the geo-
graphic distance between surgeries, two researchers in
each state carried out the interviews, one researcher to one
general practitioner interviewee. The researchers were
unknown to the general practitioners. Psychometric anal-
yses of the resultant data were conducted, including calcu-
lation of the internal consistency of the scale.
Medical record audit
Three data extraction proformas, one each for asthma,
Type II diabetes and ischaemic heart disease/hyperten-
sion, were developed from the same evidence-based
guidelines [15-18] used to develop the GPCCI. The pro-
formas were used to extract information from patients'
medical notes and were scored for analysis. Maximum
points possible were 14 (diabetes), 11 (asthma) and 9
(heart disease), creating an overall total of 34. Higher
scores indicated better clinical care. Five raters extracted
the data from the medical records in general practices
across the two states, according to a strict protocol. The
five raters were post-graduate researchers with experience
in conducting research in general practice and clinical
experience in chronic disease management.
We verified the reliability of the ratings by analysing the
data extracted from 11 patient records (three Type II dia-
betes, three IHD/hypertension, five asthma) by all five
raters. First, single rater reliabilities (or intra-class correla-
tions) were derived from analysis of variance. Single rater
reliability is defined by Marsh & Ball[22] as the correla-
tion between two independent assessments of the samePage 3 of 7
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ual items for each chronic disease. The results were used
to assess the strength of agreement between raters for each
item in each scale. Using the Spearman-Brown equation,
we then calculated reliabilities for the 5 raters for each
item.
We removed items that had the same scores from all raters
(reliability cannot be calculated) and then conducted a
reliability analysis for the adjusted total scores for each
chronic disease.
Analysis of the correlation between GPCCI and medical record audit
A comparison of the data items and coding for the GPCCI
and each of the medical record audits (for Asthma, Diabe-
tes and IHD/Hypertension) and their distributional char-
acteristics is in Appendix III [see Additional file 3]. This
shows that the proportion of codes for each element was
similar between the GPCCI and medical record audit. A
series of Pearson Product Moment Correlation analyses
were performed to ascertain the concurrent validity of the
GPCCI in relation to the medical record audit. First we
computed the correlations separately for the three disease
groups aggregated to practice level, to ascertain whether
the interview rating scale had stronger validity as three
separate scales. Then, for comparison, we conducted the
correlations on the total GPCCI, combined across the
three conditions.
All analyses were carried out using SPSS version 12.0.1 for
Windows[23].
Results
Twenty-eight general practitioners (68% male, mean age
48.8 years [SD 10.1], mean number of years practicing as
a general practitioner 20.5 [SD10.8]) consented to partic-
ipate in the study. The GPCCI took 35 minutes to admin-
ister, and up to 45 minutes if a general practitioner had
difficulty thinking of specific patients and had to consult
his/her records. Four hundred and sixty-two of their
patients with Type II diabetes, ischaemic heart disease/
hypertension and/or moderate to severe asthma (49%
male) agreed to have their medical notes reviewed.
The results are presented in the order of the analyses
undertaken: (i) internal homogeneity of the GPCCI; (ii)
inter-rater reliability analysis of the medical record audit,
and (iii) correlation of GPCCI and medical record audit.
The internal consistency of scale determined by Cron-
bach's alpha was α = 0.75 for the overall scale, compared
with α = 0.76 for the diabetes sub-scale, α = 0.49 for the
heart disease and α = 0.16 for the asthma subscale. The
latter coefficients are below the 0.7 cut-off recommended
by Nunnally[24]. Descriptive statistics for the GPCCI are
presented in Table 1.
Table 1 also presents descriptive statistics of the medical
record audit, against which the GPCCI was validated. The
inter-rater reliability estimates of the adjusted total scores
of the data extracted from patients medical notes are sum-
marised in Table 2 for each condition (Type II diabetes,
asthma, IHD/hypertension). The analysis for asthma
included five patients notes assessed by five raters, whilst
the analysis for diabetes and IHD utilised the notes of
three patients each assessed by five raters. The results dem-
onstrate that there was strong inter-rater reliability on the
adjusted total scores of data extracted from patients med-
ical notes for all three conditions (r = 0.88, r = 0.92, r =
0.90 for diabetes, asthma and heart disease respectively).
To ascertain whether the GPCCI possesses concurrent
validity, a series of Pearson Product Moment Correlation
analyses were computed on the GPCCI and patients' med-
ical notes from the same practices. First we correlated the
three disease sub-scales separately (diabetes, asthma,
heart disease) with the equivalent section of the medical
notes to determine whether the GPCCI was more valid as
three separate instruments; then we correlated the overall
scale. The results indicated that a correlation between the
GPCCI and notes audits existed both at the level of the
disease specific sub-scales (diabetes r = 0.74, asthma r =
0.89, heart disease/hypertension r = 0.0.68), and also at
the level of the overall scale (r = 0.84) (Table 2).
Discussion
Continuous monitoring and evaluation of the processes
of chronic disease management is necessary for constant
Table 1: Descriptive Statistics for the GPCCI and Medical Notes Audit (n = 10 practices)
GPCCI Medical Notes Audit CCI/Notes audit
Max Possible Mean score (95% CI) Max Possible Mean adjusted score (95% CI) Pearson Correlation Coefficient (p)
Asthma 24 10.4 (8.0–12.7) 11 3.3 (2.9–3.8) 0.74 (0.015)
Diabetes 30 18.1 (15.5–20.7) 14 7.8 (6.8–8.8) 0.89 (0.001)
IHD/Hypertension 24 11.6 (10.1–13.1) 9 4.6 (4.3–4.8) 0.68 (0.031)
Total 78 40.0 (34.0–46.0) 34 15.7 (14.1–17.3) 0.84 (0.003)Page 4 of 7
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able, sensitive and valid procedures for measuring care,
quality initiatives will not succeed[25]. In the UK, the
recently-implemented plan to improve quality across the
health system has been accompanied by central infrastruc-
ture development (the Modernisation Agency, the Com-
mission for Health Improvement, the National Institute
of Clinical Excellence), initiatives such as the National
Service Frameworks, National Performance Assessment
Framework, Clinical Governance, and a new quality-
based General Practitioner Contract[26]. These have facil-
itated the development of measures of quality, such as the
Quality and Outcomes Framework, which provides
detailed indicators across a number of conditions[27].
However the UK is unique in this regard. Elsewhere, a bot-
tom-up approach to quality improvement has been neces-
sary, and evidence-based tools for measuring quality of
care for complex conditions are rare. Rapid measures of
quality are in even shorter supply, including in the UK.
Due to the pressure of day-to-day care within general prac-
tice, it can be difficult for clinicians to systematically
record the necessary data on all their patients for subse-
quent audit. Information such as demographic data, med-
ical history, treatments, test results and family structure is
often missing[28]. General practitioners also tend to omit
recording any special aspects of care or deviations from
clinical guidelines due to patients' personal circumstances
or subjective experiences of their illness. Furthermore, the
use of special recording forms for audit exacerbates the
Hawthorne effect.
This study demonstrates that the General Practice Clinical
Care Interview may provide a useful assessment of the
self-reported quality of care provided by Australian gen-
eral practitioners to patients with chronic and complex ill-
nesses. Our results showed that it performs slightly better
psychometrically as an overall interview rating scale, than
as individual disease-specific sub-scales. As an interview
rating scale of clinical care across multiple chronic condi-
tions within a general practice, it may therefore avoid one
of the major problems of disease-specific approaches to
chronic disease management in general practice – the
problem of comorbidity. Also, it is less resource-intensive
than extracting data from medical records and avoids the
problems of missing or incomplete data inherent in such
data extraction. Lastly, it recognises the deviations from
guideline-based care based on a general practitioner's per-
sonal knowledge of the patient.
The subscales may themselves also be useful in assessing
provider-reported quality of care for the three specific dis-
eases. However, the internal consistency of the asthma
and heart disease subscales was substantially lower than
that of diabetes and the scale overall. This may reflect the
larger proportion of very specific clinical assessment items
in the diabetes sub-scale in comparison to elements for
ongoing care and practice organisation in comparison
with the other two sub-scales. It may also reflect the fact
that greater effort has been made to codify optimal care of
diabetes in general practice in the published clinical
guidelines in comparison with the other two diseases.
Other studies have evaluated the utility of questionnaires
to measure attitudes and activities related to preventive
and clinical care [29]. To our knowledge, the GPCCI is
one of the first validated rating scales of clinical care in
general practice by interview. In addition, many existing
measures of patient-centred care are patient-assessed [30];
whereas our scale acknowledges the importance of con-
sidering this aspect of care from a general practitioner per-
spective. It would be interesting to explore in more detail
cases in which general practitioners did not follow a
guideline and their justification for it: this is an area for
further development and future research.
A number of methodological limitations of the study
must be considered. In addition to the inherent problems
with audits of medical records, the use of multiple raters
of the patients' medical notes had the potential to increase
variability. We were able to offset this limitation to some
degree by demonstrating good inter-rater reliabilities, but
the study would have been stronger had it been feasible
for one rater to perform all the data extraction across Aus-
tralia. We also plan to examine the correlation between
the GPCCI and other measures of quality care especially
patient-reported measures. We were also unable to quan-
tify possible sources of error in the audit – particularly the
contribution of coding errors by assessors and errors in
the charts where aspects of care were not recorded.
This is only the first study of the validity of the GPCCI and
the findings should be considered preliminary. Further
Table 2: Reliabilities for adjusted total scores
RATING r11 r22 r33 r44 r55
Diabetes 0.59 0.74 0.81 0.85 0.88
Asthma 0.71 0.83 0.88 0.91 0.92
IHD 0.63 0.77 0.84 0.87 0.90
r11 is the single rater reliability and rkk is the reliability of k ratersPage 5 of 7
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also desirable with a larger sample of general practition-
ers. This will determine the underlying factor structure of
the instrument, which may differ from the three disease or
four processes of care components. There is also a need to
further test the external validity against other measures of
quality and its utility in studies of quality of care for
patients with chronic disease in Australian general prac-
tice.
Conclusion
The GPCCI may be a useful tool in assessing the quality of
care of chronic disease by interview in Australian general
practice. It is relatively easy to administer. This study sug-
gests that it has good internal consistency when used as an
overall scale, it has concurrent validity with patients' med-
ical records in Australian general practice and that further
evaluation of its properties, validity and utility should be
carried out.
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